期刊文献+

肉毒杆菌B诱导大鼠干眼模型中泪腺Lacritin蛋白表达的研究 被引量:2

Expression of Lacritin protein in lacrimal gland of rat dry eye model induced by botulinum toxin B
下载PDF
导出
摘要 目的建立肉毒杆菌B诱导大鼠干眼模型,通过观察泪腺Lacritin蛋白表达变化,初步探讨其在干眼症中的作用机理。方法 30只(30眼)健康8周雌性SD大鼠,随机分为2组,20只为实验组,10只为对照组。实验组右侧泪腺注射肉毒杆菌B 0.1 mL,对照组右侧泪腺注射生理盐水0.1 mL。分别于术前1 d及术后3 d、7 d、14 d、28 d、42 d观察基础泪液分泌量、角膜荧光染色。通过免疫组织化学染色和Western blot方法定性、定量分析Lacritin蛋白表达变化。结果实验组从术后3 d时出现泪液分泌减少,实验组为(2.56±0.72)mm,对照组为(3.04±0.72)mm,组间差异无统计学意义(P>0.05);实验组术后7 d、14d、28 d时分别为(2.03±0.86)mm、(2.01±0.78)mm、(1.04±0.46)mm,对照组分别为(3.01±0.42)mm、(2.78±0.54)mm、(3.00±0.21)mm,2组间差异均有统计学意义(均为P<0.05);在28 d实验组泪液分泌减少达到最低(1.04±0.46)mm;42 d后泪液分泌恢复,与对照组差异无统计学意义(P>0.05)。实验组角膜荧光染色3 d时出现,持续到42 d,除术前1 d和术后3d外,余时间点与对照组评分差异均有统计学意义(均为P<0.05)。实验组泪腺组织Lacritin蛋白含量检测显示:3 d开始减少,7 d达到最低,28 d时含量仍呈低表达,42 d开始恢复;对照组Lacritin蛋白含量各时间点未出现变化。结论泪腺注射肉毒杆菌B可以成功诱导大鼠炎症干眼模型,Lacritin蛋白的减少与眼表损坏有密切关系。 Objective Through establishing the botulinum toxin B-induced rat dry eye model, to explore the changes of lacritin protein expression in lacrimal gland and investigate its mechanism. Methods Thirty healthy female rats (30 eyes) with 8 weeks old were randomly divided into two groups,20 cases injected botulinum toxin B (0.1 mL) via lacrimal gland in right eyes (experimental group) ,and l0 cases injected saline (0. I mL, control group). Schirmer I test and corneal fluorescein staining were performed at preoperative 1 day and postoperative 3 days,7 days,14 days,28 days and 42 days, and lacritin protein expression were observed by immunohistochemical staining and Western blot. Results The result of Schirmer I test in experimental group was significantly decreased from the postoperative 3 days ( 2.55 ± 0.72 ) ram, which in con trol group was ( 3. 04 ± 0. 72 ) nun, there was no statistical difference between two groups (P 〉 0.05 ) ; The results of Schirmer I test at postoperative 7 days, 14 days and 28 days in experimental group were ( 2.03 ± 0. 86) nun, (2.01± 0.78 ) nun and ( 1.04 + 0. 45)mm, respectively, which in control group were (3. O1 ± 0.42 )nun, (2.78 ± 0.54 ) nun and (3.00 ± 0.21 )ram, respectively, there were statistical differences between two groups ( all P 〈 0.05 ) ; The result of Schirmer I test in experimental group reached the least peak at postoperative 28 days ( 1.04 ± 0.46) ram, and then returned to normal from 42 days, there was no statistical difference compared with control group (P 〉 0.05 ). The positive corneal fluorescein staining appeared at postoperative 3 days in experimental group and maintained to 42 days, except for preoperative 1 day and postoperative 3days, there were statistical differences in staining scores at other time points between two groups ( all/~ 〈 O. O~ ). Lacntm protein expression in lacrimal gland of experimental group decreased at postoperative 3 days, reached the least at 7 days and maintained to 28 days, then returned from 42 days, which in control group unchanged at different time points. Conclusion
出处 《眼科新进展》 CAS 北大核心 2014年第1期21-24,共4页 Recent Advances in Ophthalmology
基金 陕西省自然科学基金资助(编号:S2010JC376) 西安市科技计划资助项目[编号:SF1022(1)]~~
关键词 干眼 肉毒杆菌B Lacritin蛋白 dry eye botulium toxin B Lacritin
  • 相关文献

参考文献12

  • 1Nelson JD, Helms H, Fiscella R, Southwell Y, Hirsch JD. A new look at dry eye disease and its treatment [ J]. Adv Ther,2000,17 (2) :84-93.
  • 2Nakamura S, Shibuya M, Nakashima H, Imagawa T, Uehara M, Tsubota K. D-beta- hydroxylbutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board E J ] . Invest Ophthalmol Vis Sc/,2005,46(7) :2379-2387.
  • 3Smith RE. The tear film complex: pathogenesis and emerging therapies for dry eyes [ J]. Cornea, 2005,24 (1) :1-7.
  • 4De Paiva CS, Pflugfelder SC. Rationale or anti-inflammatory therapy in dry eye syndrome [ J ]. Arq Bras Oftalmol, 2008,7 (6) :89-95.
  • 5Zhu L, Shen J, Zhang C, Park CY, Kohanim S, Yew M. Inflamma- tory cytokine expresion on the ocular surface in the Botulium toxin B induced urine dry eye model [ J]. Mol Vis ,2009,15:250- 258.
  • 6Lin Z, Liu X, Zhou T, Wang Y, Bai L, He H, eta/. A mouse dry eye model induced topical administration of benzalkonium chlo- ride[ J]. Mol Vs .2011.17 ( 31-32 ) _.257-264.
  • 7Park CY, Zhuang W, Lekhanont K, Zhang C, Cano M, Lee WS, et a/. Lacrimal gland inflammatory cytokine gene expression in the botulinum toxin B-induced murine dry eye model[J]. Mol Vis, 2007,13 (252-255) :2222-2232.
  • 8Sanghi S,Kumar R,Lumsden A, Dickinson D, Klepeis V,Trinkaus- Randall V,et al. cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacrimal gland[ J ]. J Mol Biol,2001,310( ] ) :127-139.
  • 9Ma P, Beck SL, Raab RW, McKown RL, Coffman GL, Utani A, et a/. Heparanase deglycanation of syndecan-1 is required for bind- hag of the epithelial-restricted prosecretory mitogen lacritin [ J ] J CeU Biol, 2005,174 ( 7 ) : 1097 - 1105.
  • 10Koo BS, Lee DY, Ha HS, Kim JC, Kim CW. Comparative analysis of the tear protein expression ha blepharitis patients using two- dimensional electrophoresis [ J]- J Proteome Res, 2005,4 ( 3 ) : 719-724.

同被引文献23

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部